XML 78 R54.htm IDEA: XBRL DOCUMENT v3.23.1

Shareholders' Equity (Details) - Schedule of outstanding options granted	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Option [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	534,826
Options exercisable	470,710
Option [Member] | October 2013 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	5,719
Average Exercise price per share (in Dollars per share) | $ / shares	$ 5.06
Options exercisable	5,719
Exercisable	October 2023
Option [Member] | September 2014 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	5,719
Average Exercise price per share (in Dollars per share) | $ / shares	$ 5.06
Options exercisable	5,719
Exercisable	September 2024
Option [Member] | April 2016 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	5,975
Average Exercise price per share (in Dollars per share) | $ / shares	$ 3.1
Options exercisable	5,975
Exercisable	April 2026
Option [Member] | December 2016 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	7,170
Average Exercise price per share (in Dollars per share) | $ / shares	$ 3.93
Options exercisable	7,170
Exercisable	December 2026
Option [Member] | June 2017 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	197,722
Average Exercise price per share (in Dollars per share) | $ / shares	$ 4.1
Options exercisable	197,722
Exercisable	June 2027
Option [Member] | November 2017 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	17,925
Average Exercise price per share (in Dollars per share) | $ / shares	$ 7.7
Options exercisable	17,925
Exercisable	November 2027
Option [Member] | August 2019 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	71,700
Average Exercise price per share (in Dollars per share) | $ / shares	$ 8.18
Options exercisable	71,700
Exercisable	August 2029
Option [Member] | June 2020 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	64,530
Average Exercise price per share (in Dollars per share) | $ / shares	$ 6.62
Options exercisable	53,724
Exercisable	June 2030
Option [Member] | April 2021 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	62,741
Average Exercise price per share (in Dollars per share) | $ / shares	$ 9.57
Options exercisable	62,741
Exercisable	April 2031
Option [Member] | August 2021 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	15,000
Average Exercise price per share (in Dollars per share) | $ / shares	$ 8.13
Options exercisable	6,206
Exercisable	August 2031
Option [Member] | December 2021 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	10,000
Average Exercise price per share (in Dollars per share) | $ / shares	$ 6.8
Options exercisable	3,300
Exercisable	December 2031
Option [Member] | May 2022 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	65,625
Average Exercise price per share (in Dollars per share) | $ / shares	$ 5
Options exercisable	32,809
Exercisable	May 2032
Option [Member] | November 2022 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	5,000
Average Exercise price per share (in Dollars per share) | $ / shares	$ 1.05
Exercisable	November 2032
Warrant [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	413,263
Options exercisable	413,263
Warrant [Member] | August 2019 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	200,596
Average Exercise price per share (in Dollars per share) | $ / shares	$ 15.95
Options exercisable	200,596
Exercisable	August 2023
Warrant [Member] | September 2020 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	17,925
Average Exercise price per share (in Dollars per share) | $ / shares	$ 16
Options exercisable	17,925
Exercisable	September 2024
Warrant [Member] | April 2022 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	155,794
Average Exercise price per share (in Dollars per share) | $ / shares	$ 5.14
Options exercisable	155,794
Exercisable	April 2029
Warrant [Member] | July 2022 [Member]
Shareholders' Equity (Details) - Schedule of outstanding options granted [Line Items]
Options outstanding	38,948
Average Exercise price per share (in Dollars per share) | $ / shares	$ 5.14
Options exercisable	38,948
Exercisable	April 2029

X

- Definition

Options exercisable.

+ References

No definition available.

+ Details

Name:	pypd_OptionsExercisable
Namespace Prefix:	pypd_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- References

No definition available.

+ Details

Name:	pypd_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpiration
Namespace Prefix:	pypd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	pypd_ShareholdersEquityDetailsScheduleofoutstandingoptionsgrantedLineItems
Namespace Prefix:	pypd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(iii)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_OctoberTwoThousandThirteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_SeptemberTwoThousandFourteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_AprilTwoThousandSixteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_DecemberTwoThousandSixteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_JuneTwoThousandSeventeenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_NovemberTwoThousandSeventeenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_August2019Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_JuneTwoThousandTwentyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_April2021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_August2021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_December2021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_May2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_November2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_September2020Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_April2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=pypd_July2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: